ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652168; 2) Community: the network communities that were significantly associated with the response to NSC 652168; 3) Molecule: the relationships between components within communities and NSC 652168; 4) MDR: the compounds that were significantly associated with the NSC 652168.

NSC Compound Enrichment Correlation
NSC 717189 Null 0.011234153078014 0.35471115
NSC 717705 Null 0.011234153078014 0.083251308
NSC 732832 1-{2-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrol ylamino)phenylcarboxamido]ethyl}-3,4-dimethoxybenzene 0.011234153078014 0.17533712
NSC 681641 Camptothecin Derivative 0.0112341530780142 0.027024437
NSC 726365 Null 0.0112341530780142 0.30412711
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0112341530780143 0.27801909
NSC 622297 Null 0.0112341530780143 0.21866209
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.0112341530780143 -0.13394598
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0112341530780143 0.32156826
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0112341530780143 0.44392239
Total:105  Current:33    [First] [Prev] [Next] [Last]